Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Babassu nut (Attalea speciosa) contains lauric acid and type A procyanidin trimers that inhibit COX enzymes by 50-60% and bind NADPH oxidase with -11.5 kcal/mol affinity. These compounds provide antioxidant protection with an IC₅₀ of 4.734 µg/mL while supporting anti-inflammatory and antimicrobial activity.
Reported Benefits (Provisional)
Origin & History
The Babassu Nut is the fruit of the Babassu Palm (Attalea speciosa), a tree native to the tropical lowlands of Brazil and other parts of South America, thriving in the Amazon and Cerrado biomes. This nutrient-dense nut is a rich source of medium-chain triglycerides and antioxidants, making it highly valued for its functional benefits in skin, digestive, and metabolic health.
Research Narrative (Provisional)
Scientific research confirms Babassu oil's effectiveness in moisturizing skin, improving lipid profiles, and providing antioxidant defense, supported by in vitro and animal studies. Its lauric acid content has demonstrated antimicrobial and anti-inflammatory activity, while its MCTs contribute to metabolic and digestive health, with emerging human data supporting these benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Fats: Lauric Acid, Myristic Acid, Medium-Chain Triglycerides (MCTs). - Vitamins: Tocopherols (Vitamin E). - Minerals: Selenium, Magnesium (trace amounts). - Phytochemicals: Polyphenolic compounds.
Reported Mechanism (Provisional)
Babassu's type A procyanidin trimers bind NADPH oxidase and xanthine oxidase with binding energies of -11.5 and -10.4 kcal/mol respectively, while quercetin-glycosides form hydrogen bonds with active site residues. Lauric acid inhibits COX-1 by 50-60% and COX-2 by 25-30%, suppressing MAPK pathway and NF-κB activation to reduce proinflammatory cytokine production.
Clinical Narrative (Provisional)
In vitro studies demonstrate babassu mesocarp extract's antioxidant activity with an IC₅₀ of 4.734 µg/mL and lipid peroxidation inhibition at IC₅₀ of 51.35 µg/mL. Fermentation studies showed 12-hour fermented babassu flour achieved 92.76 µmol TE g⁻¹ ABTS antioxidant values and 40.26% α-glucosidase inhibition. Cell-based studies using HepG2 cells confirmed bioactive compounds retain functionality after gastrointestinal digestion and show no cytotoxic effects. However, human clinical trials are lacking, limiting evidence strength for therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.